Session » Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 73

Anti -N-Methyl-D-Aspartate Receptor Antibody Is Associated with Fibromyalgia in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 63

Association of Smoking and Cognitive Function in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 74

Clinical Characteristics of Fibromyalgia in a Chronic Pain Population

9:00AM-11:00AM: Abstract Number: 82

Cross-Sectional Analysis of Heart Rate Variability in Patients with Fibromyalgia (FM): Correlations with Baseline Clinical Measures

9:00AM-11:00AM: Abstract Number: 70

Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014

9:00AM-11:00AM: Abstract Number: 65

Disability in the Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 76

Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory

9:00AM-11:00AM: Abstract Number: 78

Exploratory Analysis of Somatic Symptoms in Fibromyalgia By Multidimensional Scaling and Latent Class Analysis

9:00AM-11:00AM: Abstract Number: 69

Fibrofog in Mild and Severe Variants of Fibromyalgia

9:00AM-11:00AM: Abstract Number: 75

Fibromyalgia and Positional Cervical Cord Compression Differ Only By Autonomic Nervous System Consequences: A Double-Blinded, Prospective Study

9:00AM-11:00AM: Abstract Number: 71

Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia Polysymptomatic Distress Scale

9:00AM-11:00AM: Abstract Number: 66

Fibromyalgia Patients Identify More Causes of Disease Flare Ups Than RA Patients

9:00AM-11:00AM: Abstract Number: 67

Higher Levels of Pro-Inflammatory and Lower Levels of Anti-Inflammatory Cytokines Are Present in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 79

Hypervigilence: Patients with Fibromyalgia Often Appear Very Sensitive to Environmental Stresses

9:00AM-11:00AM: Abstract Number: 83

Immediate Benefits of a Multidisciplinary Educational Program for Fibromyalgia on Patients’ Pain Related Self-Efficacy and Health Locus of Control

9:00AM-11:00AM: Abstract Number: 85

Low Socioeconomic Status, High Disability Rates, and Increased Use of Health Care Resources in Fibromyalgia Patients Taking Narcotics

9:00AM-11:00AM: Abstract Number: 64

Nociceptive Flexion Reflex Threshold: Possible Surrogate Marker of Symptom Severity in Fibromyalgia

9:00AM-11:00AM: Abstract Number: 80

Paresthesias in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 72

Performance of the New Survey Criteria for Fibromyalgia Under Conditions of Low and High Symptom Activity

9:00AM-11:00AM: Abstract Number: 84

Sexual Dimorphism in the Association Between Multi-Site Pain and Other Fibromyalgia Features: an Analysis of Data from Three UK Population-Based Studies

9:00AM-11:00AM: Abstract Number: 68

The Stroop Word-Naming Test in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 81

The Value of Routine Use of Creatine Kinase and Thyroid Stimulating Hormone Tests in Patients with Suspected Fibromyalgia: Results of a Cross-Sectional Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].